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ABSTRACT
Background: The purpose of this study was to assess diabetes predictive score for professional divers 
followed-up in one medical centre in France.
Materials and Methods: This prospective study, performed during 2013, included professional divers who 
were followed in a French maritime medicine centre. Data about their professional history of diving and 
dive profiles were collected. The clinical and biological data collected included: age, waist circumference, 
biometrics, body mass index, smoking status, blood pressure, practicing sports, glycaemia, triglyceridaemia, 
total cholesterolaemia, HDL and LDL cholesterolaemia. The predicted 9-year risk of diabetes was calcula-
ted according to the DESIRE score. Data were analysed using Epidata® software, by Pearson c2 test or by 
Fisher’s exact test, by analysis of variance or Kruskal-Wallis test, and by Spearman correlation coefficient.
Results: Out of the 64 deep-sea divers taking part in the study, diabetes risk was estimated for 60 divers. 
The predictive 9-year risk of diabetes was higher than 10% for 31.7% of the divers and higher than 30% 
for 6.7% of the divers. 
Conclusions: In France, people with diabetes have been declared definitely medically unfit to dive. The 
interest to assess the prevalence of risk factors and the predictive risk of diabetes arises from the need 
for prevention.
(Int Marit Health 2015; 66, 2: 87–92)
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INTRODUCTION
Professional deep-sea diving exposes the body to var-
ious forms of stress. Not only do deep-sea divers often 
have difficult tasks to perform, but their body also has to 
deal with considerable stress caused by this pressurised 
environment. We can observe this stress, in particular, 
on the cardiovascular system [1–3]: accelerating heart 
beat due to hypercapnia, impact of pressure variations in 
the airways on chest venous return, changing myocardial 
contractile function observed in animal experiments etc. 
A heart rate monitor study showed the heavy workload of 
professional deep-sea divers across a range of different 
tasks [4].
Pougnet et al. [5] studied the prevalence of cardiovas-
cular risk factors in a population of 200 deep-sea divers 
and calculated the cardiovascular risks. In their study, 66% 
of the divers had at least one modifiable risk factor which 
was obesity in 40% of this group. They also found that 0.5% 
of studied population had diabetes. This low incidence 
can be explained by the fact that, in France, diabetes is 
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a contraindication to becoming a professional deep-sea 
diver [6]. In fact, any affliction leading to possible loss 
of consciousness is incompatible with this professional 
activity in France [7]. 
Although deep-sea diving is not a diabetes risk factor, 
when professional deep-sea divers find out that they have 
diabetes, this can compromise pursuing their career. In 
consequence, maritime doctors have to prevent the risk 
for divers to develop diabetes. Divers can act on modifiable 
risk factor (overweight, smoking...). The object of this study 
is therefore to evaluate, in a population of professional 
deep-sea divers, the predicted 9-year risk of diabetes and 
to discuss ways of preventing it. 
MATERIALS AND METHODS
This was a prospective study done on professional deep-
sea divers in a Consultation Centre for Environmental, Oc-
cupational and Maritime Illnesses in a University Research 
Hospital in France, from 1st February 2013 to 31st October 
2013. The parameters were registered during the last con-
sultation carried out by a doctor. Socio-professional details 
(age, gender, work, years of service, family and medical 
history) were recorded; as well as the characteristics of 
deep-sea diving performed (how many professional and 
personal diving expeditions per year, how deep and for 
how long — average and maximum length of time); lifestyle 
(smoking, sport); body mass index (BMI); waist circumfer-
ence measurement; electrocardiogram (ECG) at rest; a car-
diac stress test and biological test results (glycaemia, total 
cholesterolaemia and triglyceridaemia, gamma glutamyl 
transferase [GGT]). Some divers also provided their HDL 
and LDL cholesterolaemia. 
The risk of diabetes was calculated using the Désir 
study model [8]. This is an adaptation of the Findrisc score 
for the French population [9, 10]. These studies showed 
that this scoring system was better adapted to the French 
population. The Désir study developed two scoring systems 
for diabetes risk over a 9 year period: a clinical score and 
a clinical-biological score. Each score was calculated dif-
ferently for men and women. The clinical score may range 
from 0 to 5; and the clinical-biological score may range from 
0 to 13 for men and from 0 to 9 for women (Table 1). The 
scores were then calculated depending on gender and 
biological and clinical parameters. 
The results were recorded and analysed using Epidata® 
software. The mean and median values of the parame-
ters were calculated. Comparison of qualitative variables 
was done using Pearson’s c2 test and Fisher’s exact test 
Table 1. Score calculation methods for clinical and clinical-biological diabetes risk over a 9 year period according to the Désir study
Variables Men Women
Clinical score
Waist measurement 70–79 cm 0 1
80–89 cm 1 2
90–99 cm 2 3
> 99 cm 3 3
Smoker 1 0
Family history of diabetes 0 1
Blood pressure ≥ 140 mm Hg and or 90 mm Hg 1 1
Clinical-biological score 
Waist measurement 70–79 cm 0 1
80–89 cm 1 2
90–99 cm 2 3
> 99 cm 3 3
Smoker 1 0
Family history of diabetes 0 1
Glycaemia 5.6–5.9 mmol/L 2 2
≥ 6 mmol/L 5 4
Gamma glutamyl transferase 20–44 UI/L 2 0
≥ 45 UI/L 3 0
Triglyceridaemia ≥ 1.1 mmol/L 0 1
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Figure 1. Number of divers according to usual diving depth
Figure 2. Numbers of dives according to usual diving duration
(depending on the validity conditions of parametric test-
ing). Quantitative variables were compared using the Krus-
kall-Wallis variance analysis test (depending on the validity 
conditions of parametric testing). Correlations were exam-
ined using Spearman’s correlation coefficient. Divers were 
divided into two groups according to their BMI (normal if 
BMI < 25, abnormal if > 25).
RESULTS
DESCRIPTION Of THE POPULATION
Sixty four divers took part in the study; 55 (86%) were 
men and 9 (14%) women (Table 1). The average age for 
women was 33 years and for men 41 years (p = 0.27). 
The type of deep-sea diving performed by divers varied 
considerably (Figs. 1, 2): 5 divers went diving for over 2 h; 
1 of them dived for up to consecutive 4 h and another diver 
went down to a depth of 80 m. 
ANALySIS Of THE CLINICAL AND  
BIOLOGICAL PARAMETERS
Analysis of the clinical score parameters showed that 
19 (30.6%) divers were smokers and 12 (19.4%) had high 
blood pressure (Table 2). Glycaemia in men were higher than 
that in women: 5.2 ± 0.5 vs. 4.8 ± 0.5 mmol/L. Amongst 
male divers, 15 (28.8%) had glycaemia over 5.6 mmol/L.
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Figure 3. Clinical score numbers and diabetes risk over 9 years according to gender
Table 2. Description of the population: divers profiles
Item
Gender Male 55 (87%) vs. female 9 (14%)
Age 40.3 ± 8.8 years
Treatment* 6 (9.5%)
Class 45 (71.4%) class 1 and  
18 (28.6%) class 2
Number of dives per year 44.1 ± 62.4; maximum 365
Usual depth of dives 16.1 ± 10.3 m; maximum 80 m
Usual duration of dives 48.9 ± 38.1 min; maximum 240 min
*1 case treated with anti-histamines, 2 with proton pump inhibitors and 3 with 
oral contraception. 
CLINICAL AND CLINICAL-BIOLOGICAL SCORES  
Of DIABETES RISk
Scores were calculated for 60 divers. Forty (66.7%) divers 
had the predicted 9-year risk of diabetes below 5% (Fig. 3). 
The predicted 9-year risk of diabetes in 19 (31.7%) divers 
was higher than 10% (Fig. 3). High clinical score was more 
frequently observed in men: 18 vs. 2 (p = 0.36) (Table 3).
Table 4 shows predicted 9-year risk of diabetes among 
male and female divers according to clinical-biological score.
DISCUSSION
Despite medical examination, some divers had a high 
diabetes risk, so that maritime doctors should act to mini-
mize this risk. Out of 64 deep-sea divers taking part in the 
study, calculation of diabetes risk was done for 60 divers. 
The predicted 9-year risk of diabetes was higher than 10% 
for 31.7% of the divers and higher than 30% for 6.7% of 
the divers. Modifiable diabetes risk factors were shown. 
For example, in this population, 28.8% had glycaemia over 
5.6 mmol/L. Maritime doctors could implement appropriate 
treatment.
Our study was, however, limited. The population studied 
was made up of 60 deep-sea divers from the same geo-
graphical area; therefore not representative of the whole 
French professional diving population. Findrisc scoring was 
not chosen, making comparisons difficult with international 
literature. However, the model chosen was used on a French 
population, aged from 30 to 64 years. Given that the centre 
in Brest monitor professional French divers with an average 
age of 40, it seemed more adapted to our population.
The interesting point of this study was to show the risk 
of developing a pathology which has both medical and 
professional consequences. There are numerous medical 
consequences: blindness caused by diabetic retinopathy 
[11]; 21% to 40% of diabetic neuropathy cases [12, 13]; up 
to 29% of occlusive arteriopathy cases of the lower limbs 
[14], not forgetting 50–70% of cases of skin conditions [15] 
and so on. Regarding professional consequences, diabe-
tes can put a stop to a career in deep-sea diving. In other 
words, in this study we can estimate that 6.7% of divers 
have over 30% risk of having to change their careers in 
a 9-year time span. 
Prevention issues are therefore doubly important for this 
population: due to health as well as professional reasons. 
This idea of prevention is also applicable to a wider field of 
epidemiological increase of type 2 diabetes within popula-
tions of Western countries from now until 2030 [16, 17]. 
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Table 3. Clinical and clinical-biological score parameters; all p value — non significant
Variables Men Women
Clinical score
Waist measurement 70–79 cm 3 (5.7%) 8 (88.9%)
80–89 cm 26 (49.1%) 0 (0%)
90–99 cm 17 (32.0%) 0 (0%)
> 99 cm 7 (13.2%) 1 (11.1%)
Smoker 17 (32.1%) 2 (22.2%)
Family history of diabetes 7 (13.2%) 3 (33.3%)
Blood pressure ≥ 140 and/or 90 mm Hg 12 (22.6%) 0 (0%)
Clinical-biological score
Glycaemia 5.6–5.9 mmol/L 10 (19.2%) 1 (11.1%)
≥ 6 mmol/L 5 (9.6%) 2 (22.2%)
Gamma glutamyl transferase 20–44 UI/L 30 (55.5%) 1 (11.1%)
≥ 45 UI/L 8 (14.8%) 0 (0%)
Triglyceridaemia ≥ 1.1 mmol/L 19 (45.3%) 3 (33.3%)
Table 4. Classification of divers by gender and overall total with high diabetes risk scores
Item Number of divers presenting a high diabetes risk in 9 years
Men Women Total
Clinical score > 3 18 (35.3%) 2 (22.2%) 20 (33.3%)
Clinical-biological score Men > 7
Women > 4
12 (23.5%) 3 (33.3%) 15 (25.0%)
The first stage of prevention is detecting cases at risk. 
Our study made it possible to show the feasibility of iden-
tifying and calculating risks for individuals using health 
care based on aptitude. The resulting preventative action 
focuses on two main areas: healthy lifestyle and diet and, 
in certain cases, use of pharmaceutical treatments. These 
lifestyle diet measures are: combatting obesity, balanced 
diet, stopping smoking, reducing alcohol consumption and 
physical activity [18]. All these measures are applicable in 
occupational health. Drug treatment measures, including 
metformin, should be discussed depending on the country 
[19, 20]. However, certified hyperbaric doctors or occupa-
tion health doctors should be able to detect divers at risk 
of diabetes and inform them of this risk. Specialist advice 
from a doctor-nutritionist or endocrinologist could reduce 
the risk of developing diabetes and, consequently, increase 
divers’ chances to stay in their careers.
CONCLUSIONS
It was possible to calculate the diabetes risk during med-
ical follow-up of professional deep-sea divers. Amongst this 
population, 31.7% of the deep-sea divers had a predicted 
9-year risk of diabetes higher than 10%. Prevention by giving 
advice on healthy lifestyle and diet seemed to be pertinent 
for this population, taking into consideration the increasing 
number of cases of this disease and the professional con-
sequences of professional divers getting diabetes.
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